New severe hemorrhagic events during the first 28 days in patients with no or mild bleeding and a platelet count less than 20 000/mm3 at initial diagnosis
| Initial therapy . | No. (%) of patients with no or mild bleeding at diagnosis . | No. (%) of such patients with new severe bleeding episode before day 28 . |
|---|---|---|
| IVIG | 146 (29) | 1 |
| Corticosteroids | 113 (22) | 0 |
| Anti-D immunoglobulin | 65 (13) | 0 |
| No drug therapy | 138 (27) | 2 |
| Multiple drug treatments/other | 41 (8) | 0 |
| Data unavailable | 2 (< 1) | 0 |
| Total | 505 | 3 (0.6%) |
| Initial therapy . | No. (%) of patients with no or mild bleeding at diagnosis . | No. (%) of such patients with new severe bleeding episode before day 28 . |
|---|---|---|
| IVIG | 146 (29) | 1 |
| Corticosteroids | 113 (22) | 0 |
| Anti-D immunoglobulin | 65 (13) | 0 |
| No drug therapy | 138 (27) | 2 |
| Multiple drug treatments/other | 41 (8) | 0 |
| Data unavailable | 2 (< 1) | 0 |
| Total | 505 | 3 (0.6%) |